Yun, Seo Jung
Lee, Ho Seok
Kim, Dae Hyun
Im, Sun
Yoo, Yeun Jie
Kim, Na Young
Lee, Jungsoo
Kim, Donghyeon
Park, Hae-Yeon
Yoon, Mi-Jeong
Kim, Young Seok
Chang, Won Hyuk
Seo, Han Gil http://orcid.org/0000-0001-6904-7542
Article History
Received: 28 April 2024
Accepted: 6 August 2024
First Online: 16 August 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board of the Samsung Medical Center, Seoul National University Hospital, Yongin Severance Hospital, and Catholic Medical Center (IRB No. 2023-12-028, 2402-073-1511, 9-2024-0015, and XC240NDS0007, respectively). Written, informed consent to participate will be obtained from all participants.
: Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding authors on request.
: DK is the CTO at NEUROPHET INC., Seoul, Republic of Korea, whose neuroimaging software was used in this study. Otherwise, there are no conflicts of interest to declare.